Dr. Bhatia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9025 Balboa Avenue
Ste 105
San Diego, CA 92123Phone+1 858-571-6800Fax+1 858-571-6801- Is this information wrong?
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Dermatology, 1995 - 1998
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1993 - 1995
- University of Wisconsin School of Medicine & Public HealthClass of 1993
Certifications & Licensure
- WI State Medical License 1994 - 2025
- CA State Medical License 1998 - 2024
- AZ State Medical License 2003 - 2011
- IA State Medical License 1998 - 2001
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
- Fellow (FASDS) American Society for Dermatologic Surgery
Clinical Trials
- Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Start of enrollment: 2014 Sep 01
- Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
- Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.Jayme Heim, Jacob Mathew, Thomas Ferro, J Gabriel Vasquez, Tina Bhutani, John Koo, Neal Bhatia> ;Dermatology and Therapy. 2024 Apr 1
- Non-specific language to describe physicians is uncommon across dermatology residency websites.Jenna Warnimont, Neal Bhatia, Abraham M Korman> ;Archives of Dermatological Research. 2024 Mar 23
- 2 citationsRoflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia, Janet DuBois, Seth B Forman, Melinda Gooderham, Lawrence Green, Scott T Guenth...> ;Journal of the American Academy of Dermatology. 2024 May 1
- Join now to see all
Press Mentions
- How Health Care Worker Dissatisfaction Is Fueling a New Trend in Health CareDecember 24th, 2022
- Rosacea and the Gut: Looking into SIBODecember 8th, 2022
- Soligenix Announces Formation of Psoriasis Medical Advisory BoardOctober 25th, 2022
- Join now to see all
Professional Memberships
- Fellow
- Fellow
Hospital Affiliations
- Harbor-UCLA Medical CenterTorrance, California
- Long Beach Medical CenterLong Beach, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: